← Back to patent-cliff list
Methoxyflurane
Tier C — Watch / tradeMethoxyflurane
Medical Developments International Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：GABAAR
Brand：Pentrox, Penthrox, Penthrane
Indications (approved)：ST段抬高型心肌梗死, 急性疼痛, 睾丸鞘膜积液, 精液囊肿, Anaesthesia, 男性生殖器官疾病, 鞘膜积血, Pain
Regional status
US
Withdrawn
EU
Phase III
2011-08-01
China
Discontinued
2022-07-28
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Methoxyflurane?
Approved indications include: ST段抬高型心肌梗死, 急性疼痛, 睾丸鞘膜积液, 精液囊肿, Anaesthesia, 男性生殖器官疾病, 鞘膜积血, Pain.
When does the Methoxyflurane patent expire?
No public expiry year is available for Methoxyflurane yet; this page updates once verified.
How do I get a quote for Methoxyflurane intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-19